For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients’ antibody development and response, suggests a new study.
Nov. 13, 2020 • ~3 min
covid-19 health-medicine ragon-institute antibody-evolution igg-antibodies
Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.
May 20, 2020 • ~8 min
covid-19 coronavirus harvard-medical-school health-medicine ragon-institute vaccine sars-cov-2 dan-h-barouch re-infection
Immunology research at the Ragon Institute of MGH, MIT, and Harvard has advanced an HIV vaccine into the clinic, and will diversify thanks to a major gift from Phillip T. and Susan M. Ragon.
Sept. 19, 2019 • ~9 min
science-technology public-health basic-research immunology bruce-walker phillip-t-terry-and-susan-m-ragon ragon-institute vaccines